Abstract:
PURPOSE: A process for preparing 4,17(20)-prostadien-3,16-dione from 5-androstene-3beta-ol-17-one and intermediate compounds for preparing the same are provided to lower values for low density lipoprotein and cholesterol and to increase a value for high density lipoprotein. CONSTITUTION: The process for preparing 4,17(20)-prostadien-3,16-dione(E-guggulsterone) represented by formula IV comprises the steps of: reacting 5-androstene-3beta-ol-17-one represented by formula I with an ethyltriphenyl phosphonium halide under a presence of a strong base to obtain a compound represented by formula II; introducing a hydroxy group to C-16 position of the obtained compound to obtain a compound represented by formula III; and oxidizing it.
Abstract:
PURPOSE: A process for preparing 4,17(20)-prostadien-3,16-dione from 16 alpha, 17 alpha-epoxypregnenolone are provided to effectively lower the values for low density lipoprotein and cholesterol and to increase the value for high density lipoprotein. CONSTITUTION: The process for preparing 4,17(20)-prostadien-3,16-dione(E-guggulsterone) represented by formula III from 16 alpha, 17 alpha-epoxypregnenolone comprises the steps of: reacting 16 alpha, 17 alpha-epoxypregnenolone represented by formula I with a hydrazine to obtain a compound represented by formula II, wherein 1 to 40 equivalent of the hydrazine is used to the 16 alpha, 17 alpha-epoxypregnenolone; and then oxidizing it using aluminum alkoxides.
Abstract:
본 발명은 인간의 페록시솜 증식자 활성화 수용체 δ(peroxisome proliferator activated receptor δ: hPPARδ)에 활성을 갖는 일반식(I)로 표시되는 티아졸 유도체를 고수율로 제조하는 신규의 방법 및 이 방법을 수행하기 위한 중간체인 일반식(II), (IV), (X), (XI) 및 (XII)과 이들의 합성방법을 제공한다.
Abstract:
PURPOSE: Provided is a method for preparing DHA(docosahexaenoic acid) and EPA(eicosapentaenoic acid) useful for food additives, which uses Lingulodinium polyedrum as a starting material to produce DHA and EPA with high purity and high yield. CONSTITUTION: The method for preparing DHA and EPA uses a dry product containing DHA and EPA obtained by freeze drying Lingulodinium polyedrum, which is dinoflagellate. The method comprises the steps of: extracting the dry product with a mixed solvent; evaporating the organic solvent layer under reduced pressure and purifying the resultant product by chromatography, or evaporating the solvent under reduced pressure and extracting the resultant residue with lower alcohol/C6-8 alkane solvent, so that fractions of lower alcohol layer can be obtained; evaporating the fractions to remove the solvent; extracting the resultant residue with ethyl acetate/water to obtain the ethyl acetate layer; mixing the ethyl acetate layer with the C6-8 alkane layer; evaporating the resultant mixture under reduced pressure and purifying the residue by chromatography.
Abstract:
PURPOSE: A process for preparing 4,17(20)-prostadien-3,16-dione from progesterone and intermediate compounds for preparing the same are provided to lower values for low density lipoprotein and cholesterol and to increase a value for high density lipoprotein. CONSTITUTION: The process for preparing 4,17(20)-prostadien-3,16-dione represented by formula VII from progesterone comprises the steps of: reducing the progesterone represented by formula I; oxidizing with a manganese dioxide; reacting with a methane sulfonyl chloride or p-toluene sulfonyl chloride; olefinating by treating the obtained compound with a strong base; selective oxidizing with a selenium compound and a peroxide; and oxidizing it.
Abstract:
PURPOSE: A process for preparing 4,17(20)-prostadien-3,16-dione from testosterone and intermediate compounds for preparing the same are provided to lower values for low density lipoprotein and cholesterol and to increase a value for high density lipoprotein. CONSTITUTION: The process for preparing 4,17(20)-E-prostadien-3,16-dione represented by formula VII from testosterone comprises the steps of: reacting testosterone represented by formula I with an alkane diol under a presence of an acid catalyst; reacting with a chrome oxide; reacting with an ethyl triphosphonium halide and a strong base; de-protecting; oxidizing with a selenium compound and a peroxide; and oxidizing it with a manganese oxide.
Abstract:
본 발명은 인간의 저밀도 지방단백질(LDL; low density lipoprotein) 및 콜레스테롤 수치를 효과적으로 낮추고, 고밀도 지방단백질(HDL; high density lipoprotein)을 높이는 것으로 알려진 일반식(IV)로 표시되는 4,17(20)- E -프로스타디엔-3,16-디온( E -Guggulsterone; E -구굴스테론)의 제조방법을 제공한다. 본 발명의 방법중 중간체인 일반식(VI)은 신규물질이다.
Abstract:
본 발명은 테스토스테론(Testosterone)으로부터 인간의 저밀도 지방단백질(LDL; low density lipoprotein) 및 콜레스테롤 수치를 효과적으로 낮추고, 고밀도 지방단백질(HDL; high density lipoprotein)을 높이는 일반식(VII)로 표시되는 4,17(20)- E -프로스타디엔-3,16-디온( E -Guggulsterone; E -구굴스테론) 및 일반식(VIII)로 표시되는 4,17(20)- Z -프로스타디엔-3,16-디온( Z -Guggulsterone; Z -구굴스테론)의 제조방법을 제공한다. 또한, 본 발명은 화합물 (VII) 또는 (VIII)을 제조하기 위한 중간체인 상기 일반식(IV) 및 (VI)을 합성하는 방법을 제공한다.
Abstract:
PURPOSE: A process for preparing 4,17(20)-prostadien-3,16-dione from 4-androstene-3,17-dione and intermediate compounds for preparing the same are provided to lower values for low density lipoprotein and cholesterol and to increase a value for high density lipoprotein. CONSTITUTION: The process for preparing 4,17(20)-E-prostadien-3,16-dione represented by formula VI from 4-androstene-3,17-dione comprises the steps of: reacting 4-androstene-3,17-dione represented by formula I with an alkane dithiol under a presence of an acid catalyst; Wittig reacting it with an ethyl triphenyl phosphonium halide in an anhydrous solvent under a strong base to obtain a compound represented by formula III; de-protecting; reacting it with a selenium compound and a peroxide; and oxidizing it.
Abstract:
본 발명은 인간의 페록시솜 증식자 활성화 수용체 δ(peroxisome proliferator activated receptor δ: hPPARδ)에 활성을 갖는 일반식(I)로 표시되는 티아졸 유도체를 고수율로 제조하는 신규의 방법 및 이 방법을 수행하기 위한 중간체인 일반식(II), (IV), (X), (XI) 및 (XII)과 이들의 합성방법을 제공한다.